Skip Navigation

European Heart Journal 1993 14(5):662-668;
Copyright © 1993 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by THOMAS, M. R.
Right arrow Articles by JEWITT, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by THOMAS, M. R.
Right arrow Articles by JEWITT, D. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 The Europen Society of Cardiology

Left ventricle filling abnormalities prior to and following treatment of thyrotoxicosis — is diastolic dysfunction implicated in thyrotoxic cardiomyopathy?

M. R. THOMAS, A. M. McGREGOR* and D. E. JEWITT

Department of Cardiology, King's College Hospital Denmark Hill, London SE5 9RS, U.K.
*Department of Medicine, King's College Hospital Denmark Hill, London SE5 9RS, U.K.

Received 11 June 1992; revised 9 November 1992; .

CorrespondenceDr D. E. Jewitt. Director of Cardiology, Department of Cardiology. King's College Hospital, Denmark Hill, London SE5 9RS. U K.

Abstract

Despite cardiac failure being a well recognised complication ofthyrotoxicosis, systolic function has generally been reported as maintained or enhanced. In this study, left ventricular diastolic function was assessed in 16 thyrotoxic patients and 18 age-matched controls by pulsed-Doppler echocardiography. Patients were re-studied after 3 and 12 months of treatment. Prior to treatment all standard Doppler-;derived indices of diastolic function were significantly different to control (isovolumic relaxation time (IVRT) 63±18.9 vs 84.0±14.8 ms, peak early filling velocity (Emax) 79.2±15.2 vs 61.9±10.7 cm . s–1, peak atrial filling velocity (Amax) 68.2±17.9 vs42.2±9.4 cm . s–1, deceleration of early filling (E/F slope) 6.1±1.8 vs3.7±1.1 m . s–1, thyrotoxic vs control). However, these filling abnormalities appear likely to reflect the tachycardia and reduced systemic vascular resistance (SVR) found in the patients (heart rate 102±15 vs 76 ± 9, SVR 874 ± 207 vs 1293 ± 362 dynes .s–1. cm–5, both P<0.001). After 3 months of treatment haemodynamics were similar in the two groups but filling remained abnormal in patients with a pattern suggesting increased transmitral pressure gradients (Emax 73.1 ± 15.1 cm.s–1, Amax 55.8 ± 19.2cm.s–1, E/F slope 4.9 ± 2.0m . s–1, all P<0.05 compared to controls). After 12 months of treatment most parameters had returned to normal but the atrial contribution to left ventricular filling remained high (Amax54.7 ± 13.9 vs control 42.2 ± 9.4 cm . s–1 .flow velocity integral of atrial filling 4.7 ± 1.3 vs 3.6±11 control, both P0.01). Left ventricular filling is therefore highly abnormal before and during the treatment ofthyrotoxicosis. However, these changes appear unlikely to reflect an intrinsic thyrotoxic cardiomyopathy and are more likely to represent a combination of prolonged increases in left ventricular filling pressures along with abnormalities of left atrial function. The abnormal Doppler parameters emphasise the importance of sinus rhythm in maintaining left ventricular filling in thyrotoxicosis and may explain why marked haemodynamic deterioration may result from the development of atrial fibrillation in these patients.

Key Words: Thyroid • heart • diastole


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.